Glucose-6-phosphate dehydrogenase deficiency and antimalarial drug development
Glucose-6-phosphate dehydrogenase (G6PD) deficiency is relatively common in populations exposed to malaria. This deficiency appears to provide some protection from this infection, but it can also cause hemolysis after administration of some antimalarial drugs, especially primaquine. The risk of drug...
Saved in:
Main Authors: | Ernest Beutler, Stephan Duparc, Ogobara Doumbo, Kanjaksha Ghosh, Marcus Vinicius Guimaraes De Lacerda, Didier Lapierre, Sornchai Looareesuwan, Zulfiqarali Premji, Tom Vulliamy, Christopher Whitty |
---|---|
Other Authors: | Scripps Research Institute |
Format: | Review |
Published: |
2018
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/24511 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
Therapeutic responses to antimalarial and antibacterial drugs in vivax malaria
by: Sasithon Pukrittayakamee, et al.
Published: (2018) -
High-performance liquid chromatographic determination of dihydroorotate dehydrogenase of Plasmodium falciparum and effects of antimalarials on enzyme activity
by: Isra Ittarat, et al.
Published: (2018) -
The future outlook of antimalarial drugs and recent work on the treatment of malaria
by: Polrat Wilairatana, et al.
Published: (2018) -
Antimalarial drug resistance: a threat to malaria elimination
by: Didier Menard, et al.
Published: (2018) -
Effects of α-thalassemia on pharmacokinetics of the antimalarial agent artesunate
by: Wanida Ittarat, et al.
Published: (2018)